A detailed history of Israel Englander (Millennium Management LLC) transactions in Xenon Pharmaceuticals Inc. stock. As of the latest transaction made, Millennium Management LLC holds 209,026 shares of XENE stock, worth $8.22 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
209,026
Previous 175,584 19.05%
Holding current value
$8.22 Million
Previous $6.85 Million 20.14%
% of portfolio
0.0%
Previous 0.0%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$36.12 - $43.96 $1.21 Million - $1.47 Million
33,442 Added 19.05%
209,026 $8.23 Million
Q2 2024

Aug 14, 2024

BUY
$36.25 - $43.75 $3.33 Million - $4.02 Million
91,923 Added 109.88%
175,584 $6.85 Million
Q1 2024

May 15, 2024

BUY
$42.66 - $50.04 $285,651 - $335,067
6,696 Added 8.7%
83,661 $3.6 Million
Q4 2023

Feb 14, 2024

SELL
$28.7 - $46.46 $3.91 Million - $6.34 Million
-136,373 Reduced 63.92%
76,965 $3.55 Million
Q2 2023

Aug 14, 2023

SELL
$34.84 - $43.54 $283,318 - $354,067
-8,132 Reduced 3.67%
213,338 $8.21 Million
Q1 2023

May 15, 2023

SELL
$33.46 - $40.35 $12.5 Million - $15.1 Million
-373,071 Reduced 62.75%
221,470 $7.93 Million
Q4 2022

Feb 14, 2023

BUY
$33.06 - $39.43 $1.13 Million - $1.35 Million
34,192 Added 6.1%
594,541 $23.4 Million
Q3 2022

Nov 14, 2022

BUY
$30.79 - $39.82 $2.08 Million - $2.69 Million
67,658 Added 13.73%
560,349 $20.2 Million
Q2 2022

Aug 15, 2022

BUY
$25.44 - $35.16 $9.07 Million - $12.5 Million
356,365 Added 261.41%
492,691 $15 Million
Q1 2022

May 16, 2022

BUY
$25.09 - $33.13 $1.15 Million - $1.51 Million
45,705 Added 50.44%
136,326 $4.17 Million
Q4 2021

Feb 14, 2022

SELL
$15.6 - $35.4 $2.27 Million - $5.15 Million
-145,598 Reduced 61.64%
90,621 $2.83 Million
Q3 2021

Nov 15, 2021

SELL
$14.86 - $19.45 $973,760 - $1.27 Million
-65,529 Reduced 21.72%
236,219 $3.61 Million
Q2 2021

Aug 16, 2021

SELL
$16.81 - $20.0 $691,748 - $823,020
-41,151 Reduced 12.0%
301,748 $5.62 Million
Q1 2021

May 17, 2021

SELL
$13.65 - $21.31 $1 Million - $1.57 Million
-73,576 Reduced 17.67%
342,899 $6.14 Million
Q4 2020

Feb 16, 2021

BUY
$9.49 - $16.04 $2.82 Million - $4.77 Million
297,630 Added 250.44%
416,475 $6.41 Million
Q3 2020

Nov 16, 2020

SELL
$10.82 - $13.35 $531,813 - $656,165
-49,151 Reduced 29.26%
118,845 $1.32 Million
Q2 2020

Aug 14, 2020

SELL
$10.21 - $14.9 $261,100 - $381,037
-25,573 Reduced 13.21%
167,996 $2.11 Million
Q1 2020

May 14, 2020

BUY
$8.08 - $17.57 $1.18 Million - $2.56 Million
145,855 Added 305.69%
193,569 $2.2 Million
Q4 2019

Feb 14, 2020

BUY
$8.11 - $14.65 $386,960 - $699,010
47,714 New
47,714 $626,000
Q2 2019

Aug 14, 2019

SELL
$8.51 - $10.75 $410,913 - $519,074
-48,286 Closed
0 $0
Q1 2019

May 14, 2019

SELL
$6.39 - $10.42 $620,443 - $1.01 Million
-97,096 Reduced 66.79%
48,286 $491,000
Q4 2018

Feb 14, 2019

BUY
$5.61 - $12.62 $350,675 - $788,863
62,509 Added 75.43%
145,382 $917,000
Q3 2018

Nov 14, 2018

BUY
$9.0 - $14.9 $745,857 - $1.23 Million
82,873 New
82,873 $1.09 Million

Others Institutions Holding XENE

About Xenon Pharmaceuticals Inc.


  • Ticker XENE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,263,500
  • Market Cap $2.45B
  • Description
  • Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...
More about XENE
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.